A recent study has linked inflammation-driven carcinogenesis in the colon to loss of an important signaling protein called SMAD4.
A new study has identified 48 candidate susceptibility genes for breast cancer risk, including 14 genes at loci (chromosome regions) not yet reported for breast cancer.
A group of young lung cancer patients and their family members recently toured research laboratories to learn how investigators are working to find better therapies and possibly a cure for the disease.
The grant from the National Cancer Institute, establishes a research center for advancing the understanding and treatment of small cell lung cancer. Vito Quaranta, M.D., will direct the new center.
A new technology may allow doctors to better distinguish benign from malignant lung nodules in CT-based lung cancer screening.
This year’s Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat focused on the association between cancer development, the immune system and the microbiome, which includes all of the microorganisms and the genetic material of these microorganisms in the human body and the surrounding environment.
Using four large-scale data sets from normal and cancerous breast tissue samples, Vanderbilt researchers have identified 101 candidate breast cancer susceptibility genes with variant-associated gene expression changes.
Vanderbilt researchers have developed a new process that can rapidly and inexpensively identify personalized cancer drugs derived from nature.
The annual Vanderbilt-Ingram Cancer Center Scientific Retreat will be held Thursday, May 3, 8 a.m. to 3 p.m. at the Vanderbilt Student Life Center. The potential link between the body’s microbiome and cancer is the topic of this year’s event.
Sirtex Medical Ltd. has renewed a grant award to Dan Brown, MD, professor of Radiology and Radiological Sciences and chief of Interventional Oncology, and his Vanderbilt Health colleagues, for a research program designed to treat patients with liver tumors that cannot be addressed with surgery.